首页> 外文期刊>Biomaterials >Patterning human stem cells and endothelial cells with laser printing for cardiac regeneration.
【24h】

Patterning human stem cells and endothelial cells with laser printing for cardiac regeneration.

机译:用激光打印为人类干细胞和内皮细胞构图,以实现心脏再生。

获取原文
获取原文并翻译 | 示例
           

摘要

Recent study showed that mesenchymal stem cells (MSC) could inhibit apoptosis of endothelial cells in hypoxic condition, increase their survival, and stimulate the angiogenesis process. In this project we applied Laser-Induced-Forward-Transfer (LIFT) cell printing technique and prepared a cardiac patch seeded with human umbilical vein endothelial cells (HUVEC) and human MSC (hMSC) in a defined pattern for cardiac regeneration. We seeded HUVEC and hMSC in a defined pattern on a Polyester urethane urea (PEUU) cardiac patch. On control patches an equal amount of cells was randomly seeded without LIFT. Patches were cultivated in vitro or transplanted in vivo to the infarcted zone of rat hearts after LAD-ligation. Cardiac performance was measured by left ventricular catheterization 8 weeks post infarction. Thereafter hearts were perfused with fluorescein tomato lectin for the assessment of functional blood vessels and stored for histology analyses. We demonstrated that LIFT-derived cell seeding pattern definitely modified growth characteristics of co-cultured HUVEC and hMSC leading to increased vessel formation and found significant functional improvement of infarcted hearts following transplantation of a LIFT-tissue engineered cardiac patch. Further, we could show enhanced capillary density and integration of human cells into the functionally connected vessels of murine vascular system. LIFT-based Tissue Engineering of cardiac patches for the treatment of myocardial infarction might improve wound healing and functional preservation.
机译:最近的研究表明,间充质干细胞(MSC)可以在缺氧条件下抑制内皮细胞的凋亡,增加其存活率,并刺激血管生成过程。在这个项目中,我们应用了激光诱导转移(LIFT)细胞印刷技术,并准备了以人脐静脉内皮细胞(HUVEC)和人MSC(hMSC)种子植入心脏的贴片,用于心脏再生。我们以定义的模式将HUVEC和hMSC播种在聚酯聚氨酯尿素(PEUU)心脏贴片上。在对照贴片上,无LIFT的情况下随机接种等量的细胞。 LAD结扎后,将贴片体外培养或体内移植到大鼠心脏的梗塞区。梗死后8周通过左心室导管测量心脏功能。此后,用荧光素番茄凝集素灌注心脏以评估功能性血管,并储存用于组织学分析。我们证明,LIFT衍生的细胞播种模式确实修饰了共培养的HUVEC和hMSC的生长特征,从而导致血管形成增加,并且在LIFT组织工程改造的心脏贴片移植后发现了梗塞心脏的显着功能改善。此外,我们可以显示增强的毛细血管密度和将人类细胞整合到小鼠血管系统的功能连接血管中。基于LIFT的用于治疗心肌梗塞的心脏补丁组织工程可能会改善伤口愈合和功能保存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号